Vascular anomalies: Classification, imaging characteristics and implications for interventional radiology treatment approaches

British Journal of Radiology

Volumn 87, Issue 1035, 2014, Pages

  Mulligan, P R ^a   Prajapati, H J S ^a   Martin, L G ^a   Patel, T H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS MALFORMATION; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE CLASSIFICATION; HUMAN; INTERVENTIONAL RADIOLOGY; LYMPHATIC MALFORMATION; NEVUS FLAMMEUS; REVIEW; TUMOR GROWTH; VASCULAR TUMOR; VEIN MALFORMATION; CAPILLARY; CLASSIFICATION; CONGENITAL MALFORMATION; HEMANGIOMA; LYMPHATIC SYSTEM; METHODOLOGY; RADIOGRAPHY; VEIN;

ARTERIOVENOUS MALFORMATIONS; CAPILLARIES; HEMANGIOMA; HUMANS; LYMPHATIC SYSTEM; PORT-WINE STAIN; RADIOGRAPHY, INTERVENTIONAL; VASCULAR MALFORMATIONS; VASCULAR NEOPLASMS; VEINS;

EID: 84908276366     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20130392     Document Type: Review

References (127)

1. Fevurly RD, Fishman SJ. Vascular anomalies in pediatrics. Surg Clin North Am 2012; 92: 769-800. doi: 10.1016/j.suc.2012.03.016
2. Marler JJ, Mulliken JB. Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am 2001; 9: 495-504.
3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-22.
4. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol 1997; 24: 701-10.
5. Lee BB, Bergan JJ. Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 2002; 10: 523-33.
6. Ernemann U, Kramer U, Miller S, Bisdas S, Rebmann H, Breuninger H, et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010; 75: 2-11. doi: 10.1016/j.ejrad.2010.04.009
7. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18: 894-900.
8. Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360-7. doi: 10.1542/peds.2007-2767
9. Leaute-Labreze C, Sans-Martin V. [Infantile hemangioma]. Presse Med 2010; 39: 499-510. doi: 10.1016/j.lpm.2009.10.015
10. Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011; 38: 45-63. doi: 10.1016/j.cps.2010.08.001
11. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107: 1647-54.
12. Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003; 6: 495-510.
13. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996; 128:329-35.
14. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-74. doi: 10.1111/j.1365-2133.2010.09848.x
15. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002; 38: 298-304. doi: 10.1290/1071-2690(2002)038,0298:BBIAIC.2.0.CO;2
16. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137: 1208-13.
17. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976; 58: 218-22.
18. Gloviczki P, Noel AA, Hollier LH. Arteriovenous fistulas and vascular malformations. In: Ascher E, Hollier LH, Strandness DE, Towne JB, Calligaro K, Kent KC, et al, eds. Haimovici's vascular surgery. 5th edn. Oxford, UK: Blackwell Science; 2004. pp. 991-1014.
19. Piram M, Lorette G, Sirinelli D, Herbreteau D, Giraudeau B, Maruani A. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol 2012; 29: 32-7. doi:10.1111/j.1525-1470.2011.01485.x
20. Ch'ng S, Tan ST. Facial port-wine stains: clinical stratification and risks of neuroocular involvement. J Plast Reconstr Aesthet Surg 2008; 61: 889-93. doi: 10.1016/j.bjps.2007.05.011
21. Tallman B, Tan OT, Morelli JG, Piepenbrink J, Stafford TJ, Trainor S, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 1991; 87: 323-7.
22. Comi AM. Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.Neurologist 2011; 17: 179-84. doi: 10.1097/NRL.0b013e318220c5b6
23. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-7.
24. Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol 1998; 139: 173-7.
25. Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993; 129: 182-8.
26. Aguilar G, Choi B, Broekgaarden M, Yang O, Yang B, Ghasri P, et al. An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann Biomed Eng 2012; 40: 486-506.
27. Franco W, Childers M, Nelson JS, Aguilar G. Laser surgery of port wine stains using local vacuum [corrected] pressure: changes in calculated energy deposition (Part II). Lasers Surg Med 2007; 39: 118-27. doi:10.1002/lsm.20464
28. Hammes S, Roos S, Raulin C, Ockenfels HM, Greve B. Does dye laser treatment with higher fluences in combination with cold air cooling improve the results of port-wine stains? J Eur Acad Dermatol Venereol 2007; 21: 1229-33. doi: 10.1111/j.1468-3083.2007.02246.x
29. Milanic M, Jia W, Nelson JS, Majaron B. Numerical optimization of sequential cryogen spray cooling and laser irradiation for improved therapy of port wine stain. Lasers Surg Med 2011; 43: 164-75. doi: 10.1002/lsm.21040
30. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther 2003; 5: 7-13.
31. Raulin C, Schroeter CA, Weiss RA, Keiner M, Werner S. Treatment of port-wine stains with a noncoherent pulsed light source: a retrospective study. Arch Dermatol 1999; 135: 679-83.
32. Qiu H, Gu Y, Wang Y, Huang N. Twenty years of clinical experience with a new modality of vascular-targeted photodynamic therapy for port wine stains. Dermatol Surg 2011; 37: 1603-10. doi: 10.1111/j.1524-4725.2011.02129.x
33. Lu YG, Wu JJ, Yang YD, Yang HZ, He Y. Photodynamic therapy of port-wine stains. J Dermatolog Treat 2010; 21: 240-4. doi:10.1080/09546630903200604
34. Loose DA. Surgical management of venous malformations. Phlebology 2007; 22: 276-82.
35. Belov S. Classification of congenital vascular defects. Int Angiol 1990; 9: 141-6.
36. Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 2010; 25: 224-35. doi: 10.1258/phleb.2009.009041
37. Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 2002; 10: 363-88.
38. Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, et al. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 1999; 212: 841-5. doi: 10.1148/radiology.212.3.r99au11841
39. Yakes WF, Rossi P, Odink H. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 1996; 19: 65-71.
40. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003; 37: 533-8. doi: 10.1067/mva.2003.91
41. Legiehn GM, Heran MK. Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin North Am 2006; 37: 435-74. doi: 10.1016/j.ocl.2006.04.005
42. Lee KB, Kim DI, Oh SK, Do YS, Kim KH, Kim YW. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation. J Vasc Surg 2008; 48: 1286-91. doi: 10.1016/j.jvs.2008.06.058
43. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004; 15: 431-45.
44. Andreisek G, Nanz D, Weishaupt D, Pfammatter T. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study. J Vasc Interv Radiol 2009; 20: 879-87. doi: 10.1016/j.jvir.2009.03.034
45. Mason KP, Michna E, Zurakowski D, Koka BV, Burrows PE. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology 2000; 217: 127-32. doi: 10.1148/radiology.217.1.r00se30127
46. Do YS, Yakes WF, Shin SW, Lee BB, Kim DI, Liu WC, et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology 2005; 235: 674-82. doi:10.1148/radiol.2352040449
47. Yakes WF, Krauth L, Ecklund J, Swengle R, Dreisbach JN, Seibert CE, et al. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 1997; 40: 1145-52; discussion 52-4.
48. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 2001; 12: 595-600.
49. Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 2005; 25: S159-71. doi: 10.1148/rg.25si055509
50. Shin BS, Do YS, Cho HS, Kim DI, Hahm TS, Kim CS, et al. Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol 2010; 21: 81-9.
51. Ko JS, Kim CS, Shin BS, Kim MJ, Lee JH, Kim KH, et al. Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period. Clin Radiol 2011; 66: 639-44. doi: 10.1016/j.crad.2011.03.003
52. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 1997; 31: 145-50.
53. Duffy DM. Sclerosants: a comparative review. Dermatol Surg 2010; 36: S1010-25. doi: 10.1111/j.1524-4725.2009.01469.x
54. Tan KT, Kirby J, Rajan DK, Hayeems E, Beecroft JR, Simons ME. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol 2007; 18: 343-51. doi: 10.1016/j.jvir.2006.12.735
55. Khandpur S, Sharma VK. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg 2010; 36: 340-6. doi: 10.1111/j.1524-4725.2009.01440.x
56. Stimpson P, Hewitt R, Barnacle A, Roebuck DJ, Hartley B. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children. Int J Pediatr Otorhinolaryngol 2012; 76: 569-73. doi: 10.1016/j.ijporl.2012.01.019
57. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008; 47: 578-84. doi: 10.1016/j.jvs.2007.11.026
58. Gulsen F, Cantasdemir M, Solak S, Gulsen G, Ozluk E, Numan F. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients. Pediatr Surg Int 2011; 27: 1283-7. doi: 10.1007/s00383-011-2962-9
59. O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 1997; 169: 723-9.
60. Goldman MP, Sadick NS. Complications and adverse sequelae of leg vein sclerotherapy. In: Nouri K, ed. Complications in dermatologic surgery. St Louis, MO: Mosby/ Elsevier; 2008. pp. 219-42.
61. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002; 28: 153-5.
62. Potter B, Gobeil F, Oiknine A, Laramee P. The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy. Can J Cardiol 2010; 26: 146-8.
63. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003; 139: 1409-16. doi:10.1001/archderm.139.11.1409
64. Dietzek CL. Sclerotherapy: introduction to solutions and techniques. Perspect Vasc Surg Endovasc Ther 2007; 19: 317-24.
65. Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol 2010; 27: 391-9. doi: 10.1055/s-0030-1267848
66. Rabe E, Breu F, Cavezzi A, Smith PC, Frullini A, Gillet J, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology Apr 2013. Epub ahead of print. doi: 10.1177/0268355513483280
67. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
68. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie 2000; 53: 129.
69. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104: 1-11.
70. Smithers CJ, Vogel AM, Kozakewich HP, Freedman DA, Burrows PE, Fauza DO, et al. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg 2005; 40: 920-5. doi: 10.1016/j.jpedsurg.2005.03.005
71. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995; 30: 188-93.
72. Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol 2003; 180: 1399-401. doi:10.2214/ajr.180.5.1801399
73. Li L, Zeng XQ, Li YH. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations. AJR Am J Roentgenol 2010; 194: W439-44. doi: 10.2214/AJR.09.3416
74. Holt PD, Burrows PE. Interventional radiology in the treatment of vascular lesions. Facial Plast Surg Clin North Am 2001; 9: 585-99.
75. Boll DT, Merkle EM, Lewin JS. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology 2004; 233: 376-84. doi: 10.1148/radiol.2332031213
76. Lee CH, Chen SG. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg 2005; 58: 1073-8. doi: 10.1016/j.bjps.2005.04.014
77. Mimura H, Kanazawa S, Yasui K, Fujiwara H, Hyodo T, Mukai T, et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama 2003; 57: 227-34.
78. Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002; 30: 416-23. doi: 10.1002/jcu.10091
79. Smith RJ. Lymphatic malformations. Lymphat Res Biol 2004; 2: 25-31.
80. Emery PJ, Bailey CM, Evans JN. Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 1984; 98: 613-19.
81. Bailey CM. Cystic hygroma. Lancet 1990; 335: 511-12.
82. Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 2011; 47: 1105-9. doi:10.1016/j.oraloncology.2011.08.001
83. Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 2005; 53: 35-45. doi: 10.1016/j.ejrad.2004.07.023
84. Kern S, Niemeyer C, Darge K, Merz C, Laubenberger J, Uhl M. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations. Acta Radiol 2000; 41: 453-7.
85. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999; 29: 879-93.
86. Meyer JS, Hoffer FA, Barnes PD, Mulliken JB. Biological classification of soft-tissue vascular anomalies: MR correlation. AJRAm J Roentgenol 1991; 157: 559-64. doi: 10.2214/ajr.157.3.1872245
87. Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000; 214: 747-54. doi: 10.1148/radiology.214.3.r00mr21747
88. Sintzoff SA Jr, Gillard I, Van Gansbeke D, Gevenois PA, Salmon I, Struyven J. Ultrasound evaluation of soft tissue tumors. J Belge Radiol 1992; 75: 276-80.
89. Boyd JB, Mulliken JB, Kaban LB, Upton J III, Murray JE. Skeletal changes associated with vascular malformations. Plast Reconstr Surg 1984; 74: 789-97.
90. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995; 30: 1282-7.
91. Zhong PQ, Zhi FX, Li R, Xue JL, Shu GY. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 139-44.
92. Zulfiqar MA, Zaleha AM, Zakaria Z, Amin T. The treatment of neck lymphangioma with intralesional injection of bleomycin. Med J Malaysia 1999; 54: 478-81.
93. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Buyukpamukcu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003; 67: 795-800.
94. Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL Jr, Hoffer FA, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 2010; 142: 795-803. doi: 10.1016/j.otohns.2010.02.026
95. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19: 766-73. doi:10.1007/s00383-003-1058-6
96. Chaudry G, Burrows PE, Padua HM, Dillon BJ, Fishman SJ, Alomari AI. Sclerotherapy of abdominal lymphatic malformations with doxycycline. J Vasc Interv Radiol 2011; 22: 1431-5. doi: 10.1016/j.jvir.2011.06.021
97. Burrows PE, Mitri RK, Alomari A, Padua HM, Lord DJ, Sylvia MB, et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008; 6: 209-16. doi: 10.1089/lrb.2008.1004
98. Cahill AM, Nijs E, Ballah D, Rabinowitz D, Thompson L, Rintoul N, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg 2011; 46: 2083-95. doi: 10.1016/j.jpedsurg.2011.07.004
99. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006; 17: 1639-48. doi: 10.1097/01.RVI.0000239104.78390.E5
100. Smith RJ, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM. OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 1996; 122: 1195-9.
101. Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987; 74: 690-1.
102. Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 2003; 26: 31-6. doi: 10.1007/s00270-002-1980-3
103. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119: 107-15. doi: 10.1002/lary.20041
104. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999; 34: 1164-8.
105. Shiels WE II, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 2008; 43: 136-9. doi: 10.1016/j.jpedsurg.2007.09.049
106. Sung MW, Lee DW, Kim DY, Lee SJ, Hwang CH, Park SW, et al. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001; 111: 1430-3. doi:10.1097/00005537-200108000-00020
107. Frieden I, Enjolras O, Esterly N. Vascular birthmarks and other abnormalities of blood vessels and lymphatics. In: Schacner LA, Hanson RC, eds. Pediatric dermatology. 3rd edn. St Louis, MO: Mosby Publishers; 2003. pp. 833-62.
108. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 1998; 102: 643-54.
109. Siegel MJ. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 2001; 39: 701-20.
110. Dubois J, Alison M. Vascular anomalies: what a radiologist needs to know. Pediatr Radiol 2010; 40: 895-905. doi: 10.1007/s00247-010-1621-y
111. Reinacher PC, Stracke P, Reinges MH, Hans FJ, Krings T. Contrast-enhanced timeresolved 3-D MRA: applications in neurosurgery and interventional neuroradiology. Neuroradiology 2007; 49(Suppl. 1): S3-13. doi: 10.1007/s00234-007-1468-6
112. Saleh RS, Lohan DG, Villablanca JP, Duckwiler G, Kee ST, Finn JP. Assessment of craniospinal arteriovenous malformations at 3T with highly temporally and highly spatially resolved contrast-enhanced MR angiography. AJNR Am J Neuroradiol 2008; 29: 1024-31. doi: 10.3174/ajnr.A0947
113. Gulati MS, Paul SB, Batra A, Sarma D, Dadhwal V, Nath J. Uterine arteriovenous malformations: the role of intravenous 'dual-phase' CT angiography. Clin Imaging 2000; 24: 10-14.
114. Savader SJ, Savader BL, Otero RR. Intraosseous arteriovenous malformations mimicking malignant disease. Acta Radiol 1988; 29: 109-14.
115. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000; 37: 517-84.
116. Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg 2010; 125: 1185-94. doi:10.1097/PRS.0b013e3181d18070
117. Cho SK, Do YS, Kim DI, Kim YW, Shin SW, Park KB, et al. Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization. Korean J Radiol 2008; 9: 258-67. doi: 10.3348/kjr.2008.9.3.258
118. Bae S, Do YS, Shin SW, Park KB, Kim DI, Kim YW, et al. Ethanol embolotherapy of pelvic arteriovenous malformations: an initial experience. Korean J Radiol 2008; 9: 148-54. doi: 10.3348/kjr.2008.9.2.148
119. Shin BS, Do YS, Lee BB, Kim DI, Chung IS, Cho HS, et al. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 2005; 235: 1072-7. doi:10.1148/radiol.2353040903
120. Loh Y, Duckwiler GR; Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 2010; 113: 733-41.
121. Pierot L, Januel AC, Herbreteau D, Barreau X, Drouineau J, Berge J, et al. Endovascular treatment of brain arteriovenous malformations using onyx: results of a prospective, multicenter study. J Neuroradiol 2009; 36: 147-52.
122. Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Vinuela F. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001; 48: 984-95.
123. Gobin YP, Laurent A, Merienne L, Schlienger M, Aymard A, Houdart E, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996; 85: 19-28. doi: 10.3171/jns.1996.85.1.0019
124. Natarajan SK, Born D, Ghodke B, Britz GW, Sekhar LN. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation. J Neurosurg 2009; 111: 105-13. doi: 10.3171/2008.12.JNS08441
125. Lee BB, Lardeo J, Neville R. Arterio-venous malformation: how much do we know? Phlebology 2009; 24: 193-200. doi: 10.1258/phleb.2009.009032
126. Do YS, Kim YW, Park KB, Kim DI, Park HS, Cho SK, et al. Endovascular treatment combined with emboloscleorotherapy for pelvic arteriovenous malformations. J Vasc Surg 2012; 55: 465-71. doi: 10.1016/j.jvs.2011.08.051
127. Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. J Vasc Interv Radiol 2004; 15: 153-60.